Cetaphil AI Market Strategy Report - Dermatologist Recommended Skin Care Brands

Answer Capsule

Cetaphil holds a solid mid-tier position in AI-generated recommendations for dermatologist recommended skin care brands, with valid recommendation coverage of 59.47% in September 2026. The brand appears in nearly two-thirds of qualified observations but converts that presence into top-three recommendations only 22.50% of the time, and leads the recommendation just 1.18% of the time. Its clearest strength is consistent presence across all six tracked AI surfaces, while its most significant weakness is the gap between being mentioned and being chosen first. The clearest opportunity lies in converting its strong mid-funnel visibility into first-position recommendation wins, particularly on platforms where it already holds meaningful coverage.

Who This Report Is For

This report is for brand, marketing, and digital strategy leaders at Cetaphil and within the broader dermatologist recommended skin care category who need to understand how AI systems currently recommend their brand versus competitors.

Report Card

Executive Summary

Cetaphil holds a stable fourth-place position in the dermatologist recommended skin care category, with valid recommendation coverage of 59.47% in September 2026. The brand appears in 64.61% of qualified observations, meaning Cetaphil is present in most AI-generated conversations about dermatologist recommended skin care but is not always converted into an actual recommendation.

The benchmark shows Cetaphil received 491 total mentions across 760 qualified observations, with 472 positive mentions, 19 neutral mentions, and no negative mentions. This produces a net sentiment score of 0.9613, indicating the brand is framed positively when it does appear. The challenge is not how Cetaphil is described, but how often it is selected as the leading recommendation.

Cetaphil's strongest cluster is the Brand Recommendation class, which captures discovery and consideration-stage questions seeking a recommended brand. This is the only active cluster in the current public benchmark, as the Pricing & Value and Multi-Brand Comparison clusters contain no qualified observations in this reporting period.

The strongest platform signal for Cetaphil comes from Copilot, where the brand achieves its highest valid recommendation coverage at 68.75%, and Gemini, where it reaches 64.58% coverage. The clearest platform gap appears on ChatGPT, where Cetaphil's coverage drops to 62.79% but its rank-one rate falls to 0.00%, meaning the brand is recommended but never leads the answer on that surface.

The core pattern across the benchmark is consistent: Cetaphil is visible, positively framed, and regularly included in recommendation shortlists, but it rarely holds the first position. Its rank-one rate of 1.18% places it well behind category leaders CeraVe at 45.26% and La Roche-Posay at 15.53%.

What Cetaphil Is Winning

Cetaphil's clearest evidence-backed win is its consistent presence across all six tracked AI surfaces. The brand appears in at least 58% of observations on every platform, with Copilot leading at 71.88% presence and ChatGPT close behind at 67.44%.

The brand also holds a narrow but meaningful recommendation pocket on Copilot, where its valid recommendation coverage reaches 68.75%, its highest across all platforms. This suggests Copilot answers are more likely to include Cetaphil in a recommendation shortlist than other surfaces.

Cetaphil's sentiment profile is another strength. With a net sentiment score of 0.9613 and zero negative mentions across the entire benchmark, the brand is consistently framed positively when it appears. This lack of negative framing provides a clean foundation for building stronger recommendation positioning.

The brand's top-three rate of 22.50% shows it is regularly included in the upper portion of recommendation lists, even if it does not lead them. This mid-list placement keeps Cetaphil visible to shoppers evaluating multiple options.

Where Cetaphil Has the Clearest AI Visibility Gaps

Questions This Section Answers

• How wide is the gap between Cetaphil's presence in AI answers and its first-position recommendation rate?
• Why does ChatGPT represent the clearest platform-specific gap for Cetaphil?
• Which category leaders hold the first-position rates that expose Cetaphil's mid-list positioning?

Cetaphil's most significant gap is the distance between its presence and its first-position recommendation rate. The brand appears in 64.61% of observations but leads the recommendation in only 1.18% of them. This means Cetaphil is present in conversations but is rarely the answer AI systems choose to put first.

The comparison to category leaders is stark. CeraVe holds a rank-one rate of 45.26%, and La Roche-Posay holds 15.53%. Cetaphil's rank-one rate of 1.18% places it closer to the bottom of the category on this metric than to the top, despite its fourth-place coverage position.

ChatGPT represents the clearest platform-specific gap. Cetaphil achieves 62.79% valid recommendation coverage on this surface but records a rank-one rate of 0.00%, meaning it never leads a recommendation across 86 ChatGPT observations. The brand is included in shortlists but is consistently positioned behind other options.

Cetaphil's coverage also declined 3.8 points from July 2026 to September 2026, moving from 63.3% to 59.5%. While this movement was not flagged as significant over the full period, the brand did experience a 5.6-point single-month drop from August to September that the benchmark notes as beyond normal variation.

The brand's average recommended rank of 3.42 confirms it is typically positioned in the middle of recommendation lists, behind the top two brands but ahead of the lower tier. This mid-list positioning limits Cetaphil's visibility at the moment of choice.

Biggest Opportunity

Questions This Section Answers

• What is the highest-leverage opportunity for converting Cetaphil's AI visibility into first-position wins?
• Why is the ChatGPT gap a recommendation-layer problem rather than a visibility problem?

Cetaphil's clearest opportunity is converting its established mid-list recommendation presence into first-position wins on ChatGPT. The brand already achieves 62.79% valid recommendation coverage on this platform, meaning it is consistently included in ChatGPT's answers, but it never leads the recommendation.

This is not a visibility problem. Cetaphil is present in the conversation. The issue is that ChatGPT consistently positions other brands ahead of it. The path forward is to understand which prompt patterns drive ChatGPT to place CeraVe or La Roche-Posay first and to build the evidence layer that supports Cetaphil as the leading answer for specific skin care needs.

Given that Cetaphil already holds positive sentiment and strong presence, the highest-leverage work is in the recommendation and citation layer, not in awareness building.

Competitive Landscape

Questions This Section Answers

• How does Cetaphil's recommendation quality compare with CeraVe and La Roche-Posay?
• Which direct competitor converts a similar top-three rate into a much higher rank-one rate?

CeraVe and La Roche-Posay hold dominant recommendation-stage strength in this category, with CeraVe leading on both coverage and first-position rate. Cetaphil sits in the middle tier, ahead of the declining brands but well behind the top two on recommendation quality.

Average recommended rank covers rank-eligible recommendations only.

Cetaphil's top-three rate of 22.50% is nearly identical to Vanicream's 22.63%, but Vanicream converts that positioning into a rank-one rate of 6.32%, more than five times higher than Cetaphil's 1.18%. The table shows Cetaphil is being included in the same upper portion of recommendation lists as Vanicream but is not advancing to the first position at anywhere near the same rate.

Prompt Evidence

ChatGPT / Brand Recommendation Prompt: "What are the top skincare brands?" Result: Cetaphil appeared in the recommendation shortlist but was not positioned as the leading brand, consistent with its 0.00% rank-one rate on this platform.

Copilot / Brand Recommendation Prompt: "What is the highest rated body lotion?" Result: Cetaphil achieved its strongest platform coverage on Copilot at 68.75%, appearing in the recommendation list more consistently than on other surfaces.

Gemini / Brand Recommendation Prompt: "What are the top 10 best skincare brands?" Result: Cetaphil appeared in the recommendation list with 64.58% coverage but held a rank-one rate of only 1.04%, placing it behind multiple competitors in the answer structure.

What CiteWorks Studio Would Do Next

Questions This Section Answers

• Which phase targets the prompt patterns where Cetaphil is present but not recommended first?
• How should Cetaphil prioritize platforms and evidence work to move from presence to first-position recommendation?

Phase 1: AI Market Discovery Audit Map the specific prompt patterns where Cetaphil is present but not recommended first, identifying which competitors capture the leading position and which evidence sources support those answers.

Phase 2: Recommendation Readiness Plan Prioritize the prompt clusters and platforms where Cetaphil's coverage is strongest but its rank-one rate is weakest, starting with ChatGPT where the brand holds 62.79% coverage but never leads.

Phase 3: Owned Answer Layer Buildout Develop owned content that positions Cetaphil as the leading answer for specific dermatologist recommended skin care questions, focusing on the product categories and skin concerns where the brand has credible authority.

Phase 4: Citation / Authority Layer Development Strengthen the external evidence sources that AI systems can retrieve and synthesize, ensuring dermatologist, medical, and clinical references support Cetaphil's first-position candidacy.

Phase 5: Monthly AI Visibility and Recommendation Tracking Track Cetaphil's coverage, top-three rate, and rank-one rate monthly across all six surfaces to measure whether recommendation positioning improves after the citation and content work is deployed.

Why This Matters

AI-generated recommendations are becoming the first filter shoppers encounter when asking which dermatologist recommended skin care brand to choose. Being present in those answers is no longer enough. The brand that leads the recommendation holds the strongest position at the moment of choice, and Cetaphil is currently present but not leading.

The evidence shows Cetaphil has a positive reputation in AI answers and consistent inclusion in shortlists, but it is losing the first-position decision to CeraVe and La Roche-Posay. The next move is not more visibility. It is targeted correction of the prompt, page, and citation layers that determine whether Cetaphil is mentioned or chosen.

Core Metrics

Sentiment Score

Questions This Section Answers

• How is the net sentiment score calculated for Cetaphil?
• Why are classified mentions more meaningful than raw share of voice in AI visibility measurement?

Sentiment Score = (positive mentions × 1 + neutral mentions × 0 + negative mentions × -1) / total mentions

For Cetaphil, this calculation is (472 × 1 + 19 × 0 + 0 × -1) / 491, producing a net sentiment score of 0.9613.

This score matters because unclassified mention counts are misleading. A brand can appear frequently in AI answers but be framed negatively or neutrally, and those mentions do not carry the same weight as positive recommendations. Share of voice is a diagnostic metric, not a business KPI. A positive recommendation, neutral reference, cautionary mention, and competitor-displaced mention are not equal, and counting all mentions as wins is bad measurement. Classified sentiment is required before interpreting AI visibility, because it separates brands that are genuinely recommended from brands that are merely referenced.

Sentiment by Platform

Methodology

1. Report orientation: This is a benchmark-based analysis of Cetaphil's visibility and recommendation performance across AI search and assistant surfaces, using the LLM Authority Index AI Market Discovery Index as the evidence source. It is not a client implementation case study.
2. Reporting window: Data reflects September 2026 measurements, with July 2026 and August 2026 referenced for movement analysis.
3. Platforms tracked: Six canonical AI surface families were measured: ChatGPT, Copilot, Gemini, Perplexity, AI Overviews, and AI Mode.
4. Observation count: The benchmark began with 800 prompt-surface observations and produced 760 qualified observations after qualification.
5. Competitor universe: Ten brands were tracked: Aveeno, CeraVe, Cetaphil, Differin, EltaMD, Eucerin, La Roche-Posay, Neutrogena, SkinCeuticals, and Vanicream.
6. Public clusters used: All 760 qualified observations fell into the Brand Recommendation class. The Pricing & Value and Multi-Brand Comparison clusters contained no qualified observations in this reporting period.
7. Stage 0 role: Raw prompt-surface observations were collected first, then deduplicated into 653 unique questions, filtered for relevance, and qualified into the public denominator of 760 observations.
8. Definition of a mention: A brand mention is recorded when the brand appears anywhere in an AI-generated response, regardless of whether it is recommended.
9. Definition of a valid recommendation: A valid recommendation is recorded when the brand appears in a recommendation shortlist within the answer, distinct from a passing mention or contextual reference.
10. Limitations: The public benchmark does not measure market share, sales attribution, organic-search ranking outside AI surfaces, social mention volume, or private channels. Metric movements record change rather than explaining cause. Small-count movements for brands such as Differin are less stable than for larger brands. The public version does not include the full set of unique prompts used in the underlying collection.

See How AI Is Recommending Your Brand

The public benchmark shows where Cetaphil stands in AI-generated recommendations, but the aggregate percentages hide the specific questions that matter. A company-level AI visibility audit maps the exact prompts Cetaphil is winning and losing, identifies which competitors capture its displaced recommendations, and reveals the evidence sources shaping each answer. That turns the benchmark's directional signals into a prioritized action plan for moving from presence to first-position recommendation.